The research submitted at PAINWeek 2019 in the city of Las Vegas, Nevada, held 3-7 September, showed that patients with chronic pain may experience an improved experience when it comes to, sleep, anxiety, and depression with the use of hemp-related cannabidiol (CBD) oil.
It is becoming a common theme that people who suffer from chronic pain now may have a solution. Chronic pain, for these purposes, can be defined as physical or mental. Either way, the use of CBD is proving time and time again, that it is helping these people, in ways that were only dreamable before. People are experiencing a pain-free existence for the first time in years. In some cases, even decades. The studies behind the true benefits are not abundant, but more and more research is being dedicated to this new development.
This research project included a total of 648 CBD petroleum patients with < 0.3% tetrahydrocannabinol. A Likert normal 11-point scale for chronic pain and related condition (e.g. insomnia, anxiety, depression and general work) evaluated the perceived advantages of the CBD item, with no change indicating a 0 and a full resolution of a 10 indication.
Study respondents revealed 122±8 days of average use of CBD oil. The progress in pain range was averaged between 4.81 and 6.48, in insomnia between 5.56 and 6.15, in anxiety between 5.36 and 5.94, in depression between 5.08 and 5.93 and in total between between five and six.50. A 4-time daily dosage of CBD oil was linked in comparative with one, two, or three-times-daily doses of the drug with statistically improvement of significant pain and associated overall condition improvements.
The constraints of this study include the retrospective nature of the study, the absence of placebo control, and self-reported evaluation results.
“The information can be used by physicians and other healthcare practitioners to reduce the opioid dose, reduce the use of prescription sleep assistance and reduce the use of anxiety benzodiazepine,” said Clinical Pain Consultant, Lead Author of research Daniel C. Roth, HR. “Overall, CBD is a helpful clinical instrument in the fight against an opioid epidemic, in relation to controlled substances engaged in accidental and illegal death overdose.”
There is a stigma around CBD, since it is originating from a plant that society has declared a “drug” for the last couple decades. However, the new research that is emerging is undeniable. The advantages to using CBD when one has chronic pain is becoming more and more clear. It is helping people. The eventual side effects are not completely known, but that is why it is crucial to dedicate more research to the development, understanding, and regulation of CBD. Pharmaceutical companies need to be in on the production of this as a “pharmaceutical drug”. As of right now, it is companies specializing in CBD that are determining dosage, the type of indigestion, and everything on the behalf of the consumer with no real data or knowledge behind it. This is why research needs to be more abundant and regulated, in order to be understood. It is undeniable that CBD is having a positive effect on many people. If it truly is a “miracle drug” then research needs to occur in order to understand what makes it work, and how it will be safe for the public to consume.